trending Market Intelligence /marketintelligence/en/news-insights/trending/ji4dy75nsrsqofqyiw-9eg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Medical cannabis producer Aphria completes merger with Nuuvera

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Medical cannabis producer Aphria completes merger with Nuuvera

Aphria Inc. completed its multimillion-dollar merger with fellow medical cannabis producer Nuuvera Inc.

The Ontario-based company paid 62 Canadian cents in cash and issued 0.3546 of an Aphria share for every stock of the target entity acquired.

Aphria had previously planned to pay 60 cents per share in cash to acquire Nuuvera.

At the time the deal was announced, Aphria said it would pay C$1 and issue 0.3546 of an Aphira share for every Nuuvera stock acquired, valuing the company at C$826 million.